Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun:95:107493.
doi: 10.1016/j.intimp.2021.107493. Epub 2021 Feb 25.

SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review

Affiliations
Review

SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review

Eijaz Ahmed Bhat et al. Int Immunopharmacol. 2021 Jun.

Abstract

The novel coronavirus disease (COVID-19) a global pandemic outbreak is an emerging new virus accountable for respiratory illness caused by SARS-CoV-2, originated in Wuhan city, Hubei province China, urgently calls to adopt prevention and intervention strategies. Several viral epidemics such as severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003 and H1N1 influenza in 2009 were reported since last two decades. Moreover, the Saudi Arabia was the epicenter for Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The CoVs are large family with single-stranded RNA viruses (+ssRNA). Genome sequence of 2019-nCoV, shows relatively different homology from other coronavirus subtypes, categorized in betacoronavirus and possibly found from strain of bats. The COVID-19 composed of exposed densely glycosylated spike protein (S) determines virus binding and infiltrate into host cells as well as initiate protective host immune response. Recently published reviews on the emerging SARS-CoV-2 have mainly focused on its structure, development of the outbreak, relevant precautions and management trials. Currently, there is an urgency of pharmacological intervention to combat this deadly infectious disease. Elucidation of molecular mechanism of COVID-19 becomes necessary. Based on the current literature and understanding, the aim of this review is to provide current genome structure, etiology, clinical prognosis as well as to explore the viral receptor binding together functional insight of SARS-CoV-2 infection (COVID-19) with treatment and preventive measures.

Keywords: COVID-19; Coronavirus; MERS-CoV; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
The timeline for emerging highly pathogenic viruses and the proposed Disease X.
Fig. 2
Fig. 2
Schematic representation of RNA genome and Structure of SARS- CoV 2. respectively (A.) Singe stranded RNA genome of SARS-CoV2 (~30 kb in length) showing with different components of genome (B.) Structure of SARS- CoV 2 is constituted of different elements such as Spike (S1 and S2), Nucleocapsid, membrane, envelope, ssRNA.
Fig.3
Fig.3
Proposed mechanisms of SARS-CoV-2 entry into the cells. Viral Receptor binding occurred through a densely S-spike protein present on outer surface of virion, responsible entry of genetic material (RNA) , which is then mRNA and host machinery starts translate into protein . The cell is then killed and releases into extracellular milieu after entering the virus into the cell.
Fig. 4
Fig. 4
Transmission Cycle of SARS-CoV2.
Fig. 5
Fig. 5
Clinical presentation of patients with COVID19.
Fig. 6
Fig. 6
Preventive measures.

References

    1. World Health Organization. “Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens.” WHO, Geneva, Switzerland, 7 (2015).
    1. World Health Organization. “Prioritizing diseases for research and development in emergency contexts.” (2019).
    1. Xu X., et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 2020;257(63):457–460. 258. - PMC - PubMed
    1. Ji W., et al. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J. Med. Virol. 2020;92:433–440. - PMC - PubMed
    1. Wu F., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. - PMC - PubMed

MeSH terms